MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalziel, J. E.
Right arrow Articles by Birnir, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalziel, J. E.
Right arrow Articles by Birnir, B.

Vol. 57, Issue 5, 875-882, May 2000

Mutating the Highly Conserved Second Membrane-Spanning Region 9' Leucine Residue in the alpha 1 or beta 1 Subunit Produces Subunit-Specific Changes in the Function of Human alpha 1beta 1 gamma -Aminobutyric AcidA Receptors

Julie E. Dalziel,1 Graeme B. Cox, Peter W. Gage, and Bryndis Birnir2

Membrane Biology Program, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia

The properties of the human alpha 1beta 1 gamma -aminobutyric acid (GABA)A receptors were investigated after mutation of a highly conserved leucine residue at the 9' position in the second membrane-spanning region (TM2). The role of this residue in alpha 1 and beta 1 subunits was examined by mutating the 9' leucine to phenylalanine, tyrosine, or alanine. The mutations were in either the alpha 1 subunit (alpha *beta ), the beta 1 subunit (alpha beta *), or in both subunits (alpha *beta *), and the receptors were expressed in Sf9 cells. Our results show that the rate of desensitization is increased as the size and hydrophobicity of the 9' residue in the alpha 1 subunit is increased: Y, F > L > A, T. Mutation of L9' in only the beta 1 subunit (alpha beta *) to either phenylalanine or tyrosine increased the EC50 value for GABA at least 100 times, but the EC50 was unchanged in alpha beta * alanine mutants. In the 9' alpha 1 mutants (alpha *beta , alpha *beta *) the GABA EC50 was minimally affected. In alpha *beta and alpha *beta *, but not alpha beta *, the peak currents evoked by millimolar concentrations of GABA were greatly reduced. The reduction in currents could only be partially accounted for by decreased expression of the receptors These findings suggest different roles for the two types of subunits in GABA activation and later desensitization of alpha 1beta 1 receptors. In addition, an increase in the resting membrane conductance was recorded in alanine but not in phenylalanine and tyrosine mutants, indicating that the side chain size at the 9' position is a major determinant of current flow in the closed conformation.


1 Present address: Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, CA.

2 Present address: Department of Cell and Molecular Physiology, Institute of Physiological Sciences, Lund University, Lund S-223 62, Sweden.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
R.-Q. Huang, Z. Chen, and G. H. Dillon
Molecular Basis for Modulation of Recombinant {alpha}1{beta}2{gamma}2 GABAA Receptors by Protons
J Neurophysiol, August 1, 2004; 92(2): 883 - 894.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Goren, D. C. Reeves, and M. H. Akabas
Loose Protein Packing around the Extracellular Half of the GABAA Receptor {beta}1 Subunit M2 Channel-lining Segment
J. Biol. Chem., March 19, 2004; 279(12): 11198 - 11205.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. T Bianchi and R. L Macdonald
Slow phases of GABAA receptor desensitization: structural determinants and possible relevance for synaptic function
J. Physiol., October 1, 2002; 544(1): 3 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Scheller and S. A. Forman
Coupled and Uncoupled Gating and Desensitization Effects by Pore Domain Mutations in GABAA Receptors
J. Neurosci., October 1, 2002; 22(19): 8411 - 8421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Engblom, B. X. Carlson, R. W. Olsen, A. Schousboe, and U. Kristiansen
Point Mutation in the First Transmembrane Region of the beta 2 Subunit of the gamma -Aminobutyric Acid Type A Receptor Alters Desensitization Kinetics of gamma -Aminobutyric Acid- and Anesthetic-induced Channel Gating
J. Biol. Chem., May 10, 2002; 277(20): 17438 - 17447.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Panicker, H. Cruz, C. Arrabit, and P. A. Slesinger
Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel
J. Neurosci., March 1, 2002; 22(5): 1629 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Reeves, E. N. Goren, M. H. Akabas, and S. C. R. Lummis
Structural and Electrostatic Properties of the 5-HT3 Receptor Pore Revealed by Substituted Cysteine Accessibility Mutagenesis
J. Biol. Chem., November 2, 2001; 276(45): 42035 - 42042.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. T. Bianchi, K. F. Haas, and R. L. Macdonald
Structural Determinants of Fast Desensitization and Desensitization-Deactivation Coupling in GABAA Receptors
J. Neurosci., February 15, 2001; 21(4): 1127 - 1136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Buhr, C. Wagner, K. Fuchs, W. Sieghart, and E. Sigel
Two Novel Residues in M2 of the gamma -Aminobutyric Acid Type A Receptor Affecting Gating by GABA and Picrotoxin Affinity
J. Biol. Chem., March 9, 2001; 276(11): 7775 - 7781.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics